Evelyne Gicquel

613 total citations
17 papers, 466 citations indexed

About

Evelyne Gicquel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Evelyne Gicquel has authored 17 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Genetics. Recurrent topics in Evelyne Gicquel's work include Muscle Physiology and Disorders (13 papers), Virus-based gene therapy research (5 papers) and Genetic Neurodegenerative Diseases (5 papers). Evelyne Gicquel is often cited by papers focused on Muscle Physiology and Disorders (13 papers), Virus-based gene therapy research (5 papers) and Genetic Neurodegenerative Diseases (5 papers). Evelyne Gicquel collaborates with scholars based in France, Finland and United Kingdom. Evelyne Gicquel's co-authors include Isabelle Richard, Marc Bartoli, Olivier Danos, Jérôme Poupiot, Françoise Fougerousse, Nathalie Danièle, Karine Charton, Carinne Roudaut, Norma Pérez and Laurence Suel and has published in prestigious journals such as The FASEB Journal, Human Molecular Genetics and Molecular Therapy.

In The Last Decade

Evelyne Gicquel

16 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evelyne Gicquel France 11 379 134 115 89 77 17 466
Nathalie Deburgrave France 13 461 1.2× 91 0.7× 109 0.9× 149 1.7× 91 1.2× 26 567
Marybeth Camboni United States 11 406 1.1× 166 1.2× 102 0.9× 67 0.8× 50 0.6× 14 478
William Nikovits United States 13 608 1.6× 134 1.0× 126 1.1× 52 0.6× 64 0.8× 15 737
Ashlee E. Tyler United States 9 481 1.3× 64 0.5× 46 0.4× 39 0.4× 41 0.5× 9 530
Fatima Amor France 9 430 1.1× 75 0.6× 49 0.4× 38 0.4× 30 0.4× 10 474
Alan G. Ridgeway Canada 10 593 1.6× 100 0.7× 58 0.5× 25 0.3× 43 0.6× 10 694
Robert E. Welikson United States 14 385 1.0× 113 0.8× 146 1.3× 27 0.3× 30 0.4× 18 487
Patricia L. Hallauer Canada 11 356 0.9× 93 0.7× 122 1.1× 23 0.3× 21 0.3× 15 407
Erik A. Toso United States 12 437 1.2× 48 0.4× 86 0.7× 26 0.3× 42 0.5× 18 557
Hülya Gündeşli Türkiye 7 343 0.9× 38 0.3× 76 0.7× 75 0.8× 124 1.6× 12 417

Countries citing papers authored by Evelyne Gicquel

Since Specialization
Citations

This map shows the geographic impact of Evelyne Gicquel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelyne Gicquel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelyne Gicquel more than expected).

Fields of papers citing papers by Evelyne Gicquel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evelyne Gicquel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelyne Gicquel. The network helps show where Evelyne Gicquel may publish in the future.

Co-authorship network of co-authors of Evelyne Gicquel

This figure shows the co-authorship network connecting the top 25 collaborators of Evelyne Gicquel. A scholar is included among the top collaborators of Evelyne Gicquel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evelyne Gicquel. Evelyne Gicquel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gicquel, Evelyne, Jérôme Poupiot, Sonsoles Campuzano, et al.. (2025). Transgene-induced cardiotoxicity in high-dose AAV gene transfer. Molecular Therapy.
2.
Bigot, Anne, et al.. (2023). CRISPR-Cas9 KO Cell Line Generation and Development of a Cell-Based Potency Assay for rAAV-FKRP Gene Therapy. Cells. 12(20). 2444–2444. 2 indexed citations
3.
Vidal, Pierre, Benjamin Bertin, Evelyne Gicquel, et al.. (2023). Muscle‐specific, liver‐detargeted adeno‐associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa−/− mice. Journal of Inherited Metabolic Disease. 47(1). 119–134. 9 indexed citations
4.
Bourg, Nathalie, Jérôme Poupiot, Karine Charton, et al.. (2022). Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy. Life Science Alliance. 6(1). e202201506–e202201506. 9 indexed citations
5.
Gicquel, Evelyne, et al.. (2022). Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies. Biomedicines. 10(6). 1428–1428. 6 indexed citations
6.
Gicquel, Evelyne, et al.. (2019). Functional and cellular localization diversity associated with Fukutin‐related protein patient genetic variants. Human Mutation. 40(10). 1874–1885. 10 indexed citations
7.
Gicquel, Evelyne, William Martin, Nathalie Bourg, et al.. (2017). AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression. Human Molecular Genetics. 26(10). 1952–1965. 35 indexed citations
8.
Richard, Isabelle, Sebahattin Çirak, John Vissing, et al.. (2016). 216th ENMC international workshop: Clinical readiness in FKRP related myopathies January 15–17, 2016 Naarden, The Netherlands. Neuromuscular Disorders. 26(10). 717–724. 13 indexed citations
9.
Blandin, Gaëlle, Sylvie Marchand, Karine Charton, et al.. (2013). A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome. Skeletal Muscle. 3(1). 3–3. 36 indexed citations
10.
11.
Charton, Karine, Nathalie Danièle, Anna Vihola, et al.. (2010). Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies. Human Molecular Genetics. 19(23). 4608–4624. 30 indexed citations
12.
Bartoli, Marc, Evelyne Gicquel, Marie Malissen, et al.. (2008). Mannosidase I inhibition rescues the human α-sarcoglycan R77C recurrent mutation. Human Molecular Genetics. 17(9). 1214–1221. 52 indexed citations
13.
Baghdiguian, Stephen, Marc Bartoli, Nathalie Danièle, et al.. (2007). NF‐NF ‐κ BB‐dependent expression of the antiapoptotic factor c‐FLIP is regulated by calpain 3, the protein involved in limb‐girdle muscular dystrophy type 2A. The FASEB Journal. 22(5). 1521–1529. 47 indexed citations
14.
Fougerousse, Françoise, Marc Bartoli, Jérôme Poupiot, et al.. (2006). Phenotypic Correction of α-Sarcoglycan Deficiency by Intra-arterial Injection of a Muscle-specific Serotype 1 rAAV Vector. Molecular Therapy. 15(1). 53–61. 55 indexed citations
15.
Bartoli, Marc, Carinne Roudaut, Samia Martin, et al.. (2005). Safety and Efficacy of AAV-Mediated Calpain 3 Gene Transfer in a Mouse Model of Limb-Girdle Muscular Dystrophy Type 2A. Molecular Therapy. 13(2). 250–259. 57 indexed citations
16.
Apparailly, Florence, Maroun Khoury, Margriet J. Vervoordeldonk, et al.. (2005). Adeno-Associated Virus Pseudotype 5 Vector Improves Gene Transfer in Arthritic Joints. Human Gene Therapy. 16(4). 426–434. 51 indexed citations
17.
Ciaccio, Paul J., et al.. (1998). Investigation of the Positive Response of Ethyl Acrylate in the Mouse Lymphoma Genotoxicity Assay. Toxicological Sciences. 46(2). 324–332. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Deburgrave Breakdown of academic impact, for papers by Marybeth Camboni Breakdown of academic impact, for papers by William Nikovits Breakdown of academic impact, for papers by Ashlee E. Tyler Breakdown of academic impact, for papers by Fatima Amor Breakdown of academic impact, for papers by Alan G. Ridgeway Breakdown of academic impact, for papers by Robert E. Welikson Breakdown of academic impact, for papers by Patricia L. Hallauer Breakdown of academic impact, for papers by Erik A. Toso Breakdown of academic impact, for papers by Hülya Gündeşli
Rankless by CCL
2026